[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365075-105":59,"doc-detail-365075-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","investigation-of-anti-cancer-properties-of-novel-curcuminoids-in-leukemic-cells-and-dalton-lymphoma-ascites-model","Investigation of Anti-Cancer Properties of Novel Curcuminoids in Leukemic Cells and Dalton Lymphoma Ascites Model","","Leukemia, a leading cause of cancer-related death, presents treatment difficulties due to substantial side effects. Building on curcumin’s anticancer and tumor-suppressing activities, this work designs and prepares 15 curcumin derivatives to address limitations including poor aqueous solubility, chemical instability, and low bioavailability. The derivatives are screened for cytotoxicity against MOLT-4 cells, prioritizing compound 5i for further study. Compared with curcumin, 5i strongly induces mitochondrial dysfunction, elevates ROS, and enhances cytotoxicity. In the Dalton’s lymphoma model, 5i reduces tumor volume with low toxicity and initiates intrinsic apoptosis by modulating Bcl-2, cytochrome c, Bak, and Bax in vivo and in vitro, showing nanomolar efficacy at least 60 times greater than curcumin.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/investigation-of-anti-cancer-properties-of-novel-curcuminoids-in-leukemic-cells-and-dalton-lymphoma-ascites-model/365075/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/investigation-of-anti-cancer-properties-of-novel-curcuminoids-in-leukemic-cells-and-dalton-lymphoma-ascites-model/365075.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why were novel curcuminoid derivatives designed for leukemia treatment?","Question",{"text":112,"@type":113},"To overcome curcumin’s shortcomings such as poor aqueous solubility, chemical instability, and low bioavailability while leveraging its known anticancer activity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which compound was prioritized after evaluating cytotoxicity against MOLT-4 cells?",{"text":117,"@type":113},"Compound 5i, identified as (2E,5E)-2,5-bis((3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)cyclopentan-1-one.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanisms of anticancer action does compound 5i show in the study?",{"text":121,"@type":113},"5i induces mitochondrial dysfunction and increases ROS production, and it triggers intrinsic apoptosis by lowering Bcl-2 and increasing cytochrome c, Bak, and Bax levels.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},365075,1790795062,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Article  \nInvestigation of Anti-Cancer Properties of Novel Curcuminoidsin Leukemic Cells and Dalton Lymphoma Ascites Model  \nVijayalakshmi Sudarshan 1, P. Shyamjith 2,†,‡, Sujeet Kumar 3,†, Febina Ravindran 2, Bibha Choudhary 2, * and Subhas S. Karki 1, *  \nAcademic Editor: Elena Dreassi  \nReceived: 28 January 2025  \nRevised: 24 March 2025  \nAccepted: 26 March 2025  \nPublished: 29 March 2025  \nCitation: Sudarshan, V.; Shyamjith, P.; Kumar, S.; Ravindran, F.; Choudhary, B.; Karki, S.S. Investigation of  \nAnti-Cancer Properties of Novel Curcuminoidsin Leukemic Cells and Dalton Lymphoma Ascites Model. Int.  \nJ. Mol. Sci. 2025, 26, 3186. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26073186](doi.org/10.3390/ijms26073186)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Pharmaceutical Chemistry, Dr. Prabhakar B Kore Basic Science Research Centre, Off-Campus, KLE College of Pharmacy (A Constituent Unit of KAHER-Belagavi), Bengaluru 560010, India; [viji2587@gmail.com](viji2587@gmail.com)  \n2 Institute of Bioinformatics and Applied Biotechnology, Electronic City Phase 1, Bengaluru 560100, India; [shyamjithp03@gmail.com](shyamjithp03@gmail.com) (P.S.); [feina28@gmail.com](feina28@gmail.com) (F.R.)  \n3 Department of Pharmaceutical Chemistry, NITTE College of Pharmaceutical Sciences (A Constituent College of Nitte Deemed to Be University, Mangaluru), Bengaluru, 560064, India; [klempharma@gmail.com](klempharma@gmail.com)  \n* [Correspondence: vibha@ibab.ac.in](Correspondence: vibha@ibab.ac.in) (B.C.); [subhashskarki@klepharmblr.org](subhashskarki@klepharmblr.org) (S.S.K.)† These authors contributed equally to this work.  \n‡ Manipal Academy of Higher Eduction, Manipal 576104, India.  \nAbstract: Leukemia, one of the major causes of cancer death, ranks 11th worldwide among cancer-related deaths. The current treatment of leukemia faces challenges recently due to a high burden of side effects. It is well established that curcumin has anticancer and tumor-suppressing activities in several cancers in addition to leukemia. Accordingly, 15 derivatives were designed and prepared to improve the shortcomings of curcumin, such as poor aqueous solubility, chemical instability, and low bioavailability. All 15 were evaluated for cytotoxicity against the leukemic cell line MOLT-4, which led to the prioritization and further evaluation of compound curcuminoid (2E,5E)-2,5-bis((3-(4-nitrophenyl)- 1-phenyl-1H-pyrazol-4-yl)methylene)cyclopentan-1-one 5i. 5i. Compared to curcumin, 5i was significantly more effective in inducing mitochondrial dysfunction in MOLT-4 cells; hence increased ROS production and cytotoxicity. Treatment groups showed change in mitochondrial membrane potential by flow cytometry analysis. Moreover, tumor volume reduction observed with 5i treatment in Dalton’s Lymphoma model was accompanied with low toxicity. Intrinsic pathways of apoptosis was initiated by compound 5i that lowered Bcl-2 expression while augmenting cytochrome c, Bak and Bax levels both in vivo and in vitro. These results showcase the potent antiproliferative as well as cytotoxic effects of 5i at nanomolar doses against leukemia being at least 60 times more effective than curcumin.  \nKeywords: curcuminoids; leukaemia; cyclopentanone derivatives; monoketone; cytotoxicity; apoptosis  \n1. Introduction  \nLeukaemia is a type of cancer that involves uncontrollable production and accumulation of blast or immature atypical blood cells in the bone marrow and peripheral blood. It ranks among the top fifteen cancers diagnosed globally [1] . Approximately 3.4% of cancer-related deaths worldwide in 2022 were attributed to leukaemia [2] . Although it can affect in","cbCaivY0vUEgEV0P","https://ap.wps.com/l/cbCaivY0vUEgEV0P","pdf",2735390,21,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"Why were novel curcuminoid derivatives designed for leukemia treatment?\",\"answer\":\"To overcome curcumin’s shortcomings such as poor aqueous solubility, chemical instability, and low bioavailability while leveraging its known anticancer activity.\"},{\"question\":\"Which compound was prioritized after evaluating cytotoxicity against MOLT-4 cells?\",\"answer\":\"Compound 5i, identified as (2E,5E)-2,5-bis((3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)cyclopentan-1-one.\"},{\"question\":\"What mechanisms of anticancer action does compound 5i show in the study?\",\"answer\":\"5i induces mitochondrial dysfunction and increases ROS production, and it triggers intrinsic apoptosis by lowering Bcl-2 and increasing cytochrome c, Bak, and Bax levels.\"}]","Investigation of Anti-Cancer Properties of Novel Curcuminoids in Leukemic Cells and Dalton Lymphoma Ascites Model | PDF",1790159940,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/431aa92391baaf45a1ec9516e4c9c6ac.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bda298d002a40668e86154dc2c8f15bb.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d6a7ac8c6d35c4d8fb5f9f509839ad0.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01a42d439ece04296cfef2f1da4f2c2f.webp",980,1385]